Using AttraX Putty to reduce pain in knee osteotomy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of AttraX® Putty as a gap filler in open-wedge osteotomies for patients with unicompartmental knee osteoarthritis. The study aims to determine if filling the osteotomy gap with this synthetic ceramic reduces early postoperative pain compared to conventional osteotomy without the filler. Secondary objectives include assessing rehabilitation speed, local blood loss, bone union, surgical accuracy, and adverse events. The trial is single-blinded and involves a randomized controlled design.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* indication for an open-wedge osteotomy of the femur, tibia or double level due to unicompartmental osteoarthritis (OA).
* Comply with all aspects of the treatment, including CT scans, radiographs and 1-year follow-up
* Informed consent

Exclusion Criteria:

* Osteotomy for indication of cartilage treatment or other knee surgeries than unicompartmental OA
* Correction using an open wedge above 10 mm
* Pregnant women at time of enrollment or women who are planning to become pregnant during the duration of the study

Where it's running

• University medical center Utrecht
  Utrecht, Utrecht, Netherlands Recruiting

Study contacts

• Principal investigator: R.J.H. Custers, Dr — UMC Utrecht
• Study coordinator: R.J.H. Custers, Dr
• Email: r.j.h.custers@umcutrecht.nl
• Phone: 088 7558327

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Arthrosamid versus steroid injections for managing knee osteoarthritis.

  This trial will test whether a single Arthrosamid hydrogel injection works better than a standard steroid plus local anesthetic injection for adults with symptomatic knee osteoarthritis.

  Recruiting Phase 4 Cappagh National Orthopaedic Hospital · Dublin, Dublin · NCT07489521

• Platelet-rich plasma plus hyaluronic acid injections for knee osteoarthritis

  We will try a single injection of platelet-rich plasma plus hyaluronic acid, platelet-rich plasma alone, or hyaluronic acid alone to see which works best for adults (40–75) with unilateral knee osteoarthritis who still have pain after conservative treatment.

  Recruiting Istituto Ortopedico Rizzoli · Bologna and 1 other locations · NCT06685120

• Evaluating OA-SYS for knee osteoarthritis treatment

  This study is testing a new treatment called OA-SYS using adult stem cells to see if it can help people with moderate to severe knee osteoarthritis feel better and improve their knee function.

  Recruiting Phase 2 Ageless Biotech, Inc. · Las Vegas, Nevada · NCT06485843

• Using bioceramic materials to repair bone defects

  This study is testing if a new type of bioceramic implant can help people heal better from bone defects compared to a standard bone implant.

  Recruiting Nanjing First Hospital, Nanjing Medical University · Nanjing, Jiangsu · NCT06249906

• Evaluating Metformin for Knee Osteoarthritis

  This study is testing if Metformin can help people aged 30 to 60 with knee osteoarthritis feel better and improve their joint function compared to another medication.

  Recruiting Phase 3 Tanta University · Damietta, New Damietta · NCT06231758

• Comparing the effects of a vegan diet to an omnivorous diet before knee surgery

  This study is testing whether a vegan diet for two weeks before knee surgery can help older adults with knee osteoarthritis build protein in their muscles and tissues better than a regular diet with meat.

  Recruiting at 2 sites Wageningen University · Arnhem and 1 other locations · NCT06130956

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.